Ishita Drugs & Industries Ltd
company logo

Ishita Drugs & Industries Ltd

Ishita Drugs Share Price

Pharmaceuticals
Small Cap

-

0 (0%)

Invest in Ishita Drugs & Industries Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

Ishita Drugs & Industries Ltd Performance

-

-

-

-


-

-

-

-

-

Ishita Drugs & Industries Ltd Fundamentals

Read More

21.49Cr

28.86

2.09

0.05

2.49

0%

34.33

Ishita Drugs & Industries Ltd Financials

Ishita Drugs & Industries Ltd Financialsright-arrow

Ishita Drugs & Industries Ltd Shareholding Pattern

Ishita Drugs & Industries Ltd Delivery and Volume

About Ishita Drugs & Industries Ltd

Ishita Drugs & Industries Limited was incorporated in Feb.'92 by Jagdish Agarwal. The Company is engaged in the manufacture of various Activa Pharma Ingredients, drug intermediates, fine chemicals and excipient. It has a state-of-art manufacturing facility, in terms of reaction capabilities, quality

Jagdish Agrawal

1992

-

NameDesignation
Jagdish AgrawalManaging Director
Abha AgrawalNon Executive Director
Niranjan AgrawalDirector
Arvind SapkalDirector
Srushti PandyaCompany Sec. & Compli. Officer
News and Events...

Similar Stocks

What's Trending

View All
View All

Ishita Drugs & Industries Ltd FAQs

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Ishita Drugs & Industries Ltd shares in BlinkX.
The share price of any stock is volatile and changes during the day due to a variety of variables. Ishita Drugs & Industries Ltd's share price is ₹71.86 as of 2024-11-21.
Ishita Drugs & Industries Ltd's P/E ratio is 28.86 times as of 2024-11-21.
Ishita Drugs & Industries Ltd's most recent financial reports indicate a price-to-book ratio of 2.09, showing the company's stock market valuation in relation to the value of its real assets.
Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Ishita Drugs & Industries Ltd's market capitalization is ₹21.49 Cr as on 2024-11-21.
The current financial records of Ishita Drugs & Industries Ltd show a 7.86% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.
According to Ishita Drugs & Industries Ltd's most recent financial filings, the company has a total asset value of ₹6.59, which includes current and non-current assets such as inventory, cash, properties, and equipment.
The 52-week high/low price of a Ishita Drugs & Industries Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Ishita Drugs & Industries Ltd's 52-week high and low as of 2024-11-21 are ₹75.85 and ₹71.8, respectively.